Arlington Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,541
Closed -$96.9K 328
2023
Q3
$96.9K Sell
1,541
-2,334
-60% -$145K 0.04% 114
2023
Q2
$219K Buy
3,875
+719
+23% +$39.9K 0.03% 148
2023
Q1
$183K Buy
3,156
+2,676
+558% +$181K 0.03% 137
2022
Q4
$34.7K Buy
+480
New +$34.4K 0.01% 247
2022
Q1
Sell
-91
Closed -$6K 571
2021
Q4
$6K Buy
+91
New +$5.71K ﹤0.01% 550
2020
Q2
Sell
-75
Closed -$2K 240
2020
Q1
$2K Buy
+75
New +$3.33K ﹤0.01% 256
2019
Q1
Sell
-380
Closed -$16K 220
2018
Q4
$16K Hold
380
0.01% 160
2018
Q3
$18K Hold
380
0.01% 179
2018
Q2
$17K Hold
380
0.02% 108
2018
Q1
$17K Buy
+380
New +$18.4K 0.02% 109

Other funds holding MET

Arlington Partners's MET Position: Q4 2023 in Review

Arlington Partners sold out of MetLife (MET) in Q4 2023, closing a stake of 1,541 shares — an estimated $96.9K sold.

Arlington Partners first reported a position in MET in Q1 2018 and held it in 10 quarters. The position peaked at $219K in Q2 2023. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • Arlington Partners reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 1,541 MetLife shares in Q4 2023, an estimated $96.9K.
  • Arlington Partners first reported a position in MetLife in Q1 2018 and held it in 10 quarters.
  • Arlington Partners's MetLife position peaked at $219K in Q2 2023.
  • 1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.